James Fetten

Memorial Sloan Kettering Cancer Center

Papers

1

Total Citations

57

H-Index

1

About

Dr. James Fetten is a leading oncologist whose research focuses on the treatment of head and neck cancers, particularly those driven by human papillomavirus (HPV). His major contributions center on the critical challenge of balancing effective cancer treatment with quality of life. As the rising incidence of HPV-positive oropharyngeal cancer creates a growing patient population with a favorable prognosis, Dr. Fetten has been at the forefront of investigating treatment deintensification. His highly cited 2022 consensus paper, which has garnered 57 citations, synthesizes global expert opinion on reducing the long-term toxicities of chemoradiation without compromising survival outcomes. This work has helped shape clinical trials and guidelines aimed at sparing patients from severe, lasting side effects. Dr. Fetten’s research is notable for its direct impact on clinical practice, moving the field toward more personalized, less morbid treatment strategies for this specific cancer subtype.

Research Focus

Key Achievements

1
H-Index
1
Papers
57
Total Citations
57
Avg Citations/Paper
🏆 Most Cited Paper
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer
57 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago